Annual Retained Earnings
-$682.07 M
-$7.60 M-1.13%
31 December 2023
Summary:
GT Biopharma annual retained earnings is currently -$682.07 million, with the most recent change of -$7.60 million (-1.13%) on 31 December 2023. During the last 3 years, it has fallen by -$86.27 million (-14.48%). GTBP annual retained earnings is now -6334.58% below its all-time high of -$10.60 million, reached on 31 December 1990.GTBP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$691.45 M
-$3.41 M-0.50%
30 September 2024
Summary:
GT Biopharma quarterly retained earnings is currently -$691.45 million, with the most recent change of -$3.41 million (-0.50%) on 30 September 2024. Over the past year, it has dropped by -$12.35 million (-1.82%). GTBP quarterly retained earnings is now -6423.13% below its all-time high of -$10.60 million, reached on 31 December 1990.GTBP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | -1.8% |
| 3 y3 years | -14.5% | -8.8% |
| 5 y5 years | -29.0% | -22.2% |
GTBP Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.5% | at low | -8.8% | at low |
| 5 y | 5 years | -29.0% | at low | -22.2% | at low |
| alltime | all time | -6334.6% | at low | -6423.1% | at low |
GT Biopharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$691.45 M(+0.5%) |
| June 2024 | - | -$688.04 M(+0.5%) |
| Mar 2024 | - | -$684.33 M(+0.3%) |
| Dec 2023 | -$682.07 M(+1.1%) | -$682.07 M(+0.4%) |
| Sept 2023 | - | -$679.10 M(+0.4%) |
| June 2023 | - | -$676.69 M(+0.3%) |
| Mar 2023 | - | -$674.70 M(+0.0%) |
| Dec 2022 | -$674.47 M(+3.2%) | -$674.47 M(+0.8%) |
| Sept 2022 | - | -$668.88 M(+1.0%) |
| June 2022 | - | -$662.00 M(+0.5%) |
| Mar 2022 | - | -$659.02 M(+0.8%) |
| Dec 2021 | -$653.58 M(+9.7%) | -$653.58 M(+2.9%) |
| Sept 2021 | - | -$635.39 M(+0.9%) |
| June 2021 | - | -$629.94 M(+0.8%) |
| Mar 2021 | - | -$625.08 M(+4.9%) |
| Dec 2020 | -$595.80 M(+5.0%) | -$595.80 M(+2.6%) |
| Sept 2020 | - | -$580.70 M(+0.5%) |
| June 2020 | - | -$577.82 M(+1.5%) |
| Mar 2020 | - | -$569.04 M(+0.3%) |
| Dec 2019 | -$567.33 M(+7.3%) | -$567.33 M(+0.3%) |
| Sept 2019 | - | -$565.86 M(+5.6%) |
| June 2019 | - | -$535.98 M(+0.5%) |
| Mar 2019 | - | -$533.20 M(+0.9%) |
| Dec 2018 | -$528.68 M(+96.2%) | -$528.68 M(+0.8%) |
| Sept 2018 | - | -$524.45 M(+81.7%) |
| June 2018 | - | -$288.67 M(+3.2%) |
| Mar 2018 | - | -$279.59 M(+3.7%) |
| Dec 2017 | -$269.50 M(+116.2%) | -$269.50 M(+2.9%) |
| Sept 2017 | - | -$261.87 M(+101.8%) |
| June 2017 | - | -$129.79 M(+2.2%) |
| Mar 2017 | - | -$126.96 M(+1.9%) |
| Dec 2016 | -$124.65 M(-7.3%) | -$124.65 M(+2.3%) |
| Sept 2016 | - | -$121.82 M(+3.1%) |
| June 2016 | - | -$118.19 M(-1.3%) |
| Mar 2016 | - | -$119.73 M(-10.9%) |
| Dec 2015 | -$134.42 M(+19.0%) | -$134.42 M(+24.1%) |
| Sept 2015 | - | -$108.30 M(+1.6%) |
| June 2015 | - | -$106.61 M(-20.1%) |
| Mar 2015 | - | -$133.47 M(+18.2%) |
| Dec 2014 | -$112.96 M(+26.3%) | -$112.96 M(+19.8%) |
| Sept 2014 | - | -$94.32 M(+4.7%) |
| June 2014 | - | -$90.10 M(+0.3%) |
| Mar 2014 | - | -$89.84 M(+0.4%) |
| Dec 2013 | -$89.47 M(+0.6%) | -$89.47 M(+0.4%) |
| Sept 2013 | - | -$89.11 M(+0.3%) |
| June 2013 | - | -$88.80 M(+0.3%) |
| Mar 2013 | - | -$88.50 M(-0.5%) |
| Dec 2012 | -$88.97 M(+6.2%) | -$88.97 M(+0.9%) |
| Sept 2012 | - | -$88.20 M(+1.6%) |
| June 2012 | - | -$86.81 M(+2.8%) |
| Mar 2012 | - | -$84.41 M(+0.7%) |
| Dec 2011 | -$83.80 M(+4.6%) | -$83.80 M(+1.4%) |
| Sept 2011 | - | -$82.66 M(-0.0%) |
| June 2011 | - | -$82.68 M(+0.8%) |
| Mar 2011 | - | -$82.02 M(+2.4%) |
| Dec 2010 | -$80.09 M(+3.9%) | -$80.09 M(+0.8%) |
| Sept 2010 | - | -$79.43 M(+0.8%) |
| June 2010 | - | -$78.80 M(-0.5%) |
| Mar 2010 | - | -$79.20 M(+2.7%) |
| Dec 2009 | -$77.10 M(+3.0%) | -$77.10 M(+1.8%) |
| Sept 2009 | - | -$75.76 M(+0.4%) |
| June 2009 | - | -$75.50 M(+0.5%) |
| Mar 2009 | - | -$75.14 M(+0.4%) |
| Dec 2008 | -$74.85 M(+7.2%) | -$74.85 M(+0.8%) |
| Sept 2008 | - | -$74.27 M(+1.1%) |
| June 2008 | - | -$73.47 M(+3.6%) |
| Mar 2008 | - | -$70.94 M(+1.6%) |
| Dec 2007 | -$69.85 M(-0.7%) | -$69.85 M(-0.4%) |
| Sept 2007 | - | -$70.13 M(+0.2%) |
| June 2007 | - | -$70.01 M(-1.5%) |
| Mar 2007 | - | -$71.09 M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | -$70.32 M(+7.6%) | -$70.32 M(+4.5%) |
| Sept 2006 | - | -$67.30 M(+1.0%) |
| June 2006 | - | -$66.65 M(+0.9%) |
| Mar 2006 | - | -$66.07 M(+1.1%) |
| Dec 2005 | -$65.38 M(+5.0%) | -$65.38 M(+3.6%) |
| Sept 2005 | - | -$63.14 M(+0.5%) |
| June 2005 | - | -$62.82 M(+0.5%) |
| Mar 2005 | - | -$62.52 M(+0.4%) |
| Dec 2004 | -$62.27 M(+4.7%) | -$62.27 M(+1.5%) |
| Sept 2004 | - | -$61.33 M(+0.1%) |
| June 2004 | - | -$61.28 M(+2.0%) |
| Mar 2004 | - | -$60.09 M(+1.0%) |
| Dec 2003 | -$59.49 M(+1.3%) | -$59.49 M(+0.4%) |
| Sept 2003 | - | -$59.27 M(+0.2%) |
| June 2003 | - | -$59.13 M(+0.5%) |
| Mar 2003 | - | -$58.85 M(+0.3%) |
| Dec 2002 | -$58.70 M(+1.4%) | -$58.70 M(+0.3%) |
| Sept 2002 | - | -$58.54 M(+0.5%) |
| June 2002 | - | -$58.24 M(+0.3%) |
| Mar 2002 | - | -$58.08 M(+0.3%) |
| Dec 2001 | -$57.88 M(+6.4%) | -$57.88 M(+0.4%) |
| Sept 2001 | - | -$57.66 M(+0.6%) |
| June 2001 | - | -$57.29 M(+3.2%) |
| Mar 2001 | - | -$55.53 M(+2.1%) |
| Dec 2000 | -$54.39 M(+9.3%) | -$54.39 M(+2.7%) |
| Sept 2000 | - | -$52.94 M(+2.2%) |
| June 2000 | - | -$51.82 M(+2.2%) |
| Mar 2000 | - | -$50.72 M(+1.9%) |
| Dec 1999 | -$49.75 M(+9.8%) | -$49.75 M(+0.9%) |
| Sept 1999 | - | -$49.30 M(+2.1%) |
| June 1999 | - | -$48.30 M(+3.9%) |
| Mar 1999 | - | -$46.50 M(+2.6%) |
| Dec 1998 | -$45.30 M(+18.6%) | -$45.30 M(+4.6%) |
| Sept 1998 | - | -$43.30 M(+5.1%) |
| June 1998 | - | -$41.20 M(+3.0%) |
| Mar 1998 | - | -$40.00 M(+4.7%) |
| Dec 1997 | -$38.20 M(+15.8%) | -$38.20 M(+3.0%) |
| Sept 1997 | - | -$37.10 M(+3.9%) |
| June 1997 | - | -$35.70 M(+3.8%) |
| Mar 1997 | - | -$34.40 M(+4.2%) |
| Dec 1996 | -$33.00 M(+22.2%) | -$33.00 M(+4.8%) |
| Sept 1996 | - | -$31.50 M(+4.7%) |
| June 1996 | - | -$30.10 M(+5.2%) |
| Mar 1996 | - | -$28.60 M(+5.9%) |
| Dec 1995 | -$27.00 M(+49.2%) | -$27.00 M(+7.1%) |
| Sept 1995 | - | -$25.20 M(+23.5%) |
| June 1995 | - | -$20.40 M(+7.9%) |
| Mar 1995 | - | -$18.90 M(+4.4%) |
| Dec 1994 | -$18.10 M(+43.7%) | -$18.10 M(+4.0%) |
| Sept 1994 | - | -$17.40 M(+33.8%) |
| June 1994 | - | -$13.00 M(+1.6%) |
| Mar 1994 | - | -$12.80 M(+1.6%) |
| Dec 1993 | -$12.60 M(+13.5%) | -$12.60 M(+0.8%) |
| Sept 1993 | - | -$12.50 M(+3.3%) |
| June 1993 | - | -$12.10 M(+9.0%) |
| Mar 1993 | - | -$11.10 M(0.0%) |
| Dec 1992 | -$11.10 M(+3.7%) | -$11.10 M(+1.8%) |
| Sept 1992 | - | -$10.90 M(+1.9%) |
| June 1992 | - | -$10.70 M(-1.8%) |
| Mar 1992 | - | -$10.90 M(+1.9%) |
| Dec 1991 | -$10.70 M(+0.9%) | -$10.70 M(+0.9%) |
| Sept 1991 | - | -$10.60 M(0.0%) |
| Dec 1990 | -$10.60 M(-26.4%) | -$10.60 M(-26.4%) |
| Dec 1989 | -$14.40 M(+18.0%) | -$14.40 M(+18.0%) |
| Dec 1988 | -$12.20 M(-0.8%) | -$12.20 M(-0.8%) |
| Dec 1987 | -$12.30 M(-2.4%) | -$12.30 M(-2.4%) |
| Dec 1986 | -$12.60 M(+3.3%) | -$12.60 M(+3.3%) |
| Dec 1985 | -$12.20 M(+2.5%) | -$12.20 M(+2.5%) |
| Dec 1984 | -$11.90 M(0.0%) | - |
| Dec 1984 | - | -$11.90 M |
| Feb 1984 | -$11.90 M | - |
FAQ
- What is GT Biopharma annual retained earnings?
- What is the all time high annual retained earnings for GT Biopharma?
- What is GT Biopharma annual retained earnings year-on-year change?
- What is GT Biopharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for GT Biopharma?
- What is GT Biopharma quarterly retained earnings year-on-year change?
What is GT Biopharma annual retained earnings?
The current annual retained earnings of GTBP is -$682.07 M
What is the all time high annual retained earnings for GT Biopharma?
GT Biopharma all-time high annual retained earnings is -$10.60 M
What is GT Biopharma annual retained earnings year-on-year change?
Over the past year, GTBP annual retained earnings has changed by -$7.60 M (-1.13%)
What is GT Biopharma quarterly retained earnings?
The current quarterly retained earnings of GTBP is -$691.45 M
What is the all time high quarterly retained earnings for GT Biopharma?
GT Biopharma all-time high quarterly retained earnings is -$10.60 M
What is GT Biopharma quarterly retained earnings year-on-year change?
Over the past year, GTBP quarterly retained earnings has changed by -$12.35 M (-1.82%)